Comparative study of anti-inflammatory activity of aqueous and methanolic extracts of hibiscus cannabinus leaf (Malvaceae) by Shaikh, Saba
 Original Article 
COMPARATIVE STUDY OF ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS AND METHANOLIC 
EXTRACTS OF HIBISCUS CANNABINUS LEAF (MALVACEAE) 
 
SABA SHAIKH*1, Y. M. JOSHI2, VILASRAO KADAM2 
1Department of Pharmacology, Anjuman-I-Islam Kalsekar Techical Campus, School of Pharmacy, New Panvel, Navi Mumbai 410206, 
Maharashtra, India, 2Department of Pharmacology, Bharati Vidyapeeth’s College of Pharmacy, Sector-8 C. B. D. Belapur, Navi Mumbai 
400614, Maharashtra, India 
Email: shaikhsaba66@gmail.com    
 Received: 04 Dec 2015 Revised and Accepted: 11 Feb 2016 
ABSTRACT 
Objective: The present study was undertaken to investigate and compare the anti-inflammatory activity of an aqueous and methanolic extract of 
Hibiscus cannabinus (Malvaceae) using carrageenan-induced rat paw edema. 
Methods: Aqueous and methanolic extracts of Hibiscus cannabinus was prepared and tested for anti-inflammatory activity in female spargue dawley 
rat weighing 150-180 g. The animals were randomly divided into 6 groups of 6 each. First group served as vehicle control, second group served as 
standard, third and fourth group served as high (400 mg/kg) and low (200 mg/kg) dose of methanolic extract of Hibiscus cannabinus leaves (MHCL) 
respectively and fifth and sixth group as high (400 mg/kg) and low (200 mg/kg) dose of aqueous extract of Hibiscus cannabinus leaves (AHCL) 
respectively. The In vivo anti-inflammatory activity was studied using carrageenan induce rat paw edema animal model. The estimation of liver and 
blood parameters consist of serum glutamic oxalate transaminase (SGOT), serum glutamic pyruvate transaminase (SGPT), lipid peroxidation (LPO), 
reduced glutathione (GSH) and superoxide dismutase (SOD). 
Results: Both MHCL and AHCL extracts showed significant (*p<0.05) inhibition of rat paw edema in dose-dependent manner. The maximum percent 
inhibition in paw edema was found in MHCL at dose of 400 mg/kg was 52.00% and AHCL at dose of 400 mg/kg was 49.93%. Both MHCL and AHCL 
at dose of 400 mg/kg reduce LPO level as 31.10 nmol/g and 35.23 nmol/g respectively when compared with standard indomethacin. 
Conclusion: An anti-inflammatory activity was found in both MHCL and AHCL extracts. But the MHCL showed more significant anti-inflammatory activity. 
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INTRODUCTION 
The word inflammation is derived from the Latin “inflammare” (to 
burn). It is one of the most important processes involved in the 
defense of an organism against local injury and infections; however 
it often progresses to a chronic disease requiring pharmacological 
treatment [1].  
According to the world health organization (WHO), about three-
quarters of world population relies upon traditional remedies 
(mainly herbs) for their health care. Herbs/plants are oldest friends 
of mankind they not only provide food and shelter but also served 
the humanity to cure different ailments. The herbal medicines also 
called traditionally, or natural medicine existed in different cultures 
and civilization. Ayurveda and Chinese medicinal systems are the 
most acceptable traditional system which has a considerable 
amount of research on pharmacognosy, chemistry, pharmacology 
and clinical therapeutics [2]. Hibiscus cannabinus belongs to the 
family Malvaceae is an Indian plant, which has a number of 
therapeutic value in the traditional system of medicine. Hibiscus 
cannabinus is an erect annual herb, measures up to 2 m tall in the wild 
and up to 5 m in cultivars. The taproot is well-developed, measures up 
to 25 cm deep with lateral roots spread horizontally to 1 m and the 
adventitious roots on lowest stem section. The stem is slender and 
cylindrical. In cultivation, it is unbranched and smooth, prickly on wild 
accessions, entirely green, green with red or purple pigmentation or 
red sometimes lower half green and upper half pigmented [3]. The 
crude extract of Hibiscus cannabinus has shown various activities 
including haematinic activity [4], fungitoxicity activity [5], antioxidant 
activity [6], immunomodulatory [7], hepatoprotective [4], antidiabetic 
activity [8] and anti-hyperlipidemic activity [9]. From the previous 
studies, Hibsicus cannabinus shown good antioxidant and immuno-
modulatory activity. However, the anti-inflammatory activity on a 
leaf of Hibiscus cannabinus is spare.  
Hence, here is an attempt to evaluate and compare the anti-
inflammatory activity of an aqueous and methanolic extract of 
Hibiscus cannabinus. 
MATERIALS AND METHODS 
Plant materials 
The plant material was collected from the local vegetable market of 
panvel, Navi Mumbai in the month of September and authenticated 
from the Botany Department, khalsa college College Mumbai. 
(Voucher No ss/130912a). Freshly collected leaves of Hibiscus 
cannabinus were dried under shade. Dried leaves were ground to a 
coarse powder with an electrical blender.  
Extraction and sample preparation 
Methanolic extract of Hibiscus cannabinus leaves (MHCL) 
Plant powder (10 g) was successively extracted with 250 ml of 
methanol (90%) in a Soxhlet apparatus at 75 °C 10 to 12 h. Extracts 
were filtered through Whatman no.1 filter paper. The extracts were 
concentrated by rotary evaporator till all the solvent had completely 
evaporated from mixtures. 
Aqueous extract of Hibiscus cannabinus leaves (AHCL) 
The powdered plant material was mixed with distilled water (1:5) 
and magnetically stirred in a separate container for overnight at 
room temperature. The residue was removed by filtration through 
Whatman no.1 filter paper, and the aqueous extracts were 
lyophilized and stored in airtight containers. 
Chemicals 
Indomethacin (Sigma), Carrageenan (Sigma) and all other chemicals 
were of analytical grade. 
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Animals 
Adult female Spargue Dawley rats (150-180 g) were procured from 
Glenmark Research Centre, Plot no. a-607, TTC industrial area M. I.D. 
C, Mahape, Navi Mumbai. The animal house was maintained on 12 h 
light/dark cycle at 22±2 °C, relative humidity 60-70% and the 
animals were provided with standard laboratory diet and water ad 
libetum. The study protocol was approved by Institutional Animal 
Ethics Committee, Mumbai (approval no-IAEC/PR/2012/01) prior 
to the commencement of experimental work. 
Methods 
Carrageenan induces rat paw edema model  
In this method, rats were divided into 6 groups of 6 animals in each. 
Paw edema was induced by injecting 0.1 ml of 1% carrageenan in 
sterile saline subcutaneously into the sub-plantar region of the rat 
right hind paw of the animals which were pre-treated with normal 
saline 2 ml/kg (Control), indomethacin 10 mg/kg (Standard), MHCL 
200 mg/kg, MHCL 400 mg/kg, AHCL 200 mg/kg and AHCL 400 
mg/kg, 30 min before the carrageenan injection. The paw volume 
was measured plethysm metrically before administering 
carrageenan, 0.5, 1, 2, 3, 4, 5 and 6 h after. Inhibition of Inflammation 
was calculated as the increase in volume (ml) of the paw after 
treatment [10]. The percentage inhibition of edema was calculated 
by the following equation.  
% Inhibition of edema = 100 (1-Vt/Vc). Where Vc is the edema volume 
in the control group and Vt is the edema volume in tested group. 
Biochemical parameters 
Biochemical parameter in serum 
After recording the paw edema, the blood samples were collected by 
retro-orbital route. Serum was separated from each sample and 
used for the biochemical analysis. The collected serum was used for 
estimation of SGOT and SGPT enzymes using commercially available 
standard enzymatic kits [11]. 
Biochemical parameter in liver 
After blood collection, the animals were sacrificed. Immediately 
after sacrificing the animals, liver was separated, wash with pH 7.4 
buffer, blotted with dry filter paper and liver weight was recorded. A 
part of the liver was minced and then homogenized in pH 7.4 buffer 
to prepare 10% w/v tissue homogenate. The homogenate was 
centrifuged at 3000 rpm for 15 min at 4 °C and the supernatant was 
used for estimation of LPO, GSH and SOD [12]. 
Lipid peroxidation (LPO)  
Reagents-TCA-TBA-HCL Reagent: 15 g of TCA (trichloroacetic acid), 
0.375 g (thiobarbituric acid) were dissolved in 100 ml 0.25N HCI. 
This solution was slightly heated to assist in the dissolution of TBA, 
Phosphate buffer pH 7.4, Test samples 10 % w/v liver homogenate 
in phosphate buffer pH 7.4. 
Vortex all tubes for few seconds. Heat for 15 min in boiling water 
bath and then cool to room temperature. Centrifuge the tubes at 
1000 g for 10 min then pipette out supernatant in the cuvette and 
read O. D at 535 nm against blank [12]. 
Calculation: nmol of MDA/g of liver tissue = O. D × 156m-1 cm-1 
Reduced glutathione (GSH)  
Reagents: Precipitating solution: Trichloroacetic acid (10 %w/v), 
Phosphate solution: 0.1M KHPO3 solution in H2O, DTNB reagent: 0.25 
mmol [5, 5/-dithiobis (2-nitrobenzoic acid)] 
Procedure 
 Reagent   Blank (ml)  Test (ml) 
Tissue homogenate -  1 
Distilled water  1 - 
TCA-TBA-HCL 
Reagent 
 2  2 
 
Calculation: GSH content of test samples was calculated by 
extrapolation method using standard graph. The result was 
expressed in nmol/g [13]. 
Another part of the liver was minced and then homogenized in pH 
7.0 buffers to prepare 10% w/v tissue homogenate. The homogenate 
was centrifuged at 3000 rpm for 15 min at 4 °C and the supernatant 
was used for estimation of superoxide dismutase. 
Superoxide dismutase (SOD)  
Procedure: A 10 %w/v tissue homogenate was prepared in 0.1 M 
phosphate buffer (pH 7.0). The reaction was initiated by addition of 
0.5 ml of hydroxylamine hydrochloride to the reaction mixture 
containing 2 ml of nitroblue tetrazolium (NBT) and 0.1 ml of liver 
homogenate. Change in absorbance was measured 
spectrophotometrically at 560 nm [14]. Calculation: The enzyme 
activity was expressed as a unit of SOD nmol/min/g liver wt. 
 
Procedure: Standard: following procedure was followed for preparation of standard curve 
S. No.  Tube no/reagent Volume (ml) 
 Conc. Of GSH (µg/ml) 1 2 3 4 5 
  5 10 15 20 25 
1. GSH Dilution 0.2 0.2 0.2 0.2 0.2 
2. Distilled water 1.8 1.8 1.8 1.8 1.8 
3 Precipitating solution 3.0 3.0 3.0 3.0 3.0 
Stand for 5 min, filter, 2 ml filtrate added to 
4. Phosphate solution  
(in cuvette) 
2.0 2.0 2.0 2.0 2.0 
5. DTNB 1.0 1.0 1.0 1.0 1.0 
Read O. D at 412 nm 
Test: following procedure was followed for the estimation of liver reduced glutathione content of test sample. 
 
S. No. Reagent  Blank (ml) Test(ml) 
1. Liver homogenate -  0.2 
2. Distilled water -  1.8 
3. Precipitating solution  2  3.0 
Stand for 5 min, filter, 2 ml filtrate added to 
4. Phosphate solution  2.0  2.0 
5. DTNB  1.0  1.0 
 Read O. D at 412 nm 
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Statistical analysis  
Results were expressed as mean±Standard Error Mean (SEM). 
Differences were considered significant at ***P<0.001, or **P<0.01 or 
*P<0.05 when compared test groups v/s control group Statistical 
analysis was performed using One-way analysis of variance 
(ANOVA) followed by Dunnett’s t-test.* P<0.05 was considered 
statistically significant, and all graphs were made by using Graph 
Pad Prism6 software. 
RESULTS 
In vivo carrageenan-induced rat paw edema 
As seen in table 1, both the extracts of Hisbiscus cannabinus and 
indomethacin significantly decreased carrageenan-induced rat paw 
edema. The anti-inflammatory effects of 400 mg/kg dose of MHCL 
and AHCL were determined as 52.00 % and 49.93 % respectively at 
3 h. For the same hour, a 200 mg/kg dose of MHCL and AHCL 
produced 46.66 % and 44.00 % anti-inflammatory effects 
respectively. In comparison, the anti-inflammatory effect of 
indomethacin was 58.04 % for the same time. These results suggest 
that the methanolic and aqueous extract of Hibiscus cannabinus leaves 
exhibits the anti-inflammatory property in the acute phase of 
inflammation but the anti-inflammatory activity is more significant in 
methanolic extract than aqueous extract and mechanism of action may 
be associated with inhibition of the some of the inflammatory 
mediators like histamine, serotonin, bradykinins and prostaglandins. 
Hibiscus cannabinus is a very common plant, and it is widely grown 
as a vegetable or fiber crop. The herb has been used in the treatment 
of various inflammatory disorders such as rheumatism, asthma, and 
burning sensation. Hence, there is a need to validate and provide a 
scientific basis for the claimed medicinal properties of the herb. 
Inflammation is an integral part of the body’s defense mechanism. 
 Acute inflammation is characterized by vasodilatation, exudation of 
plasma, release of various inflammatory mediators, cytokines, 
growth factors and emigration of leukocytes. Carrageenan-induced 
rat paw edema is a standard experimental model of acute 
inflammation. Carrageenan is a phlogistic agent of choice for testing 
anti-inflammatory drugs, as it is not known to be antigenic and is 
devoid of any apparent systemic effects [10]. 
 
Table 1: In-vivo anti-inflammatory activity of MHCL and AHCL [mean±SEM, n= 6] significant * P<0.05 when compared to control 
 EDEMA volume (ml) 
Time 
(h) 
Control 
(vehicle, p. o) 
Indomethacin 
(10 mg/kg) 
MHCL (200 mg/kg) AHCL 
(200 mg/kg) 
MHCL (400 mg/kg) AHCL (400 mg/kg) 
 0 0.00 0.00 0.00 0.00 0.00 0.00 
0.5 0.27±0.04 0.24±0.03 
(11%) 
0.26±0.03 
(3.70%) 
0.26±0.02 
(3.70%) 
0.25±0.02 
(7.40%) 
0.25±0.02 
(7.40%) 
 1 0.34±0.02 0.25±0.04* 
(26.47%) 
0.28±0.03* 
(17.64%) 
0.29±0.02* 
(14.70%) 
0.26±0.01* 
(23.52%) 
0.27±0.02* 
(20.58%) 
 2 0.55±0.05 0.34±0.01* 
(38.18%) 
0.42±0.03* 
(23.63%) 
0.44±0.02* 
(20.00%) 
0.39±0.05* 
(29.09%) 
0.41±0.02* 
(25.45%) 
 3 0.75±0.02 0.31±0.02* 
(58.04%) 
0.40±0.05* 
(46.66%) 
0.42±0.02* 
(44.00%) 
0.36±0.03* 
(52.00%) 
0.38±0.01* 
(49.93%) 
 4 0.62±0.07 0.29±0.04* 
(52.70%) 
0.38±0.02 
(38.70%) 
0.41±0.05 
(33.87%) 
0.34±0.02* 
(45.16%) 
0.36±0.01 
(41.93%) 
 5 0.51±0.02 0.26±0.05* 
(48.00%) 
0.36±0.04 
(29.41%) 
0.38±0.05 
(25.49%) 
0.32±0.02* 
(37.25%) 
0.34±0.01 
(33.33%) 
 6 0.45±0.03 0.29±0.04* 
(35.55%) 
0.39±0.02 
(13.33%) 
0.41±0.03 
(8.88%) 
0.35±0.04* 
(22.22%) 
0.37±0.01 
(17.77%) 
 
Moreover, the experimental model exhibits a high degree of 
reproducibility and is least affected by non-specific factors and 
variations in strain, sex or body weight [12]. Subcutaneous injection 
of carrageenan into the rat paw produces inflammation resulting 
from plasma extravasations [13], increased tissue water and plasma 
protein exudation along with neutrophil extravasation, all due to 
metabolism of arachidonic acid both by the cyclooxygenase and/or 
lipoxygenase enzyme pathways [14] and also due to activated kinin-
forming components and histamine [15]. It has been reported that 
carrageenan-induced edema is a biphasic response. The 1st phase is 
mediated through the release of histamine and serotonin [16]. The 
edema maintained between the first phase and the second phase is 
due to the release of kinin-like substances [17]. Whereas 2nd 
accelerating phase of swelling is attributed to the cyclo-oxygenase 
products i.e. prostaglandins [15] and a slow reacting substance with 
a peak value at 3 h [18]. The prostaglandin phase corresponds with 
the migration of a large number of leukocytes involved seem to be 
predominantly the polymorphonuclear type. The mononuclear type 
may be in lesser numbers than polymorphonuclear cells, at least 
early in the response [19]. The distinct phases of edema response 
obtained in our study subsequent to the injection of carrageenan 
were in confirmation with these reports as shown in table-1. There 
was a gradual increase in paw edema volume in the control group. 
The oral pre-treatment with MHCL and AHCL showed an inhibition 
of edema formation at the 1st phase and also in the 2nd phase of 
carrageenan-evoked hind paw edema. 
 
Serum glutamate oxaloacetate transaminase (SGOT)  
 
Fig. 1: Effect of MHCL, AHCL and indomethacin on SGOT level [mean±SEM, n= 6] significant ** p<0.01 when compared with control 
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Serum glutamate pyruvate transaminase (SGPT)  
 
Fig. 2: Effect of MHCL, AHCL and indomethacin on SGPT level [mean±SEM, n= 6] significant ** p<0.01, *** p<0.001 when compared with control 
 
Lipid peroxidation assay  
 
Fig. 3: Lipid peroxidation assay of MHCL, AHCL and Indomethacin [mean±SEM, n= 6] significant * p<0.05, ** p<0.01, **** p<0.0001 when 
compared with control 
 
Reduced glutathione assay (GSH)  
 
Fig. 4: GSH Assay of MHCL, AHCL and Indomethacin [mean±SEM, n= 6] significant * p<0.05, *** p<0.001 when compared with control 
 
Superoxide dismutase assay (SOD) 
 
Fig. 5: SOD Assay of MHCL, AHCL and Indomethacin [mean±SEM, n= 6] significant * p<0.05, *** p<0.001 when compared with control 
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Glutamic oxaloacetic transaminases (GOT) is a mitochondrial 
enzyme present in the highest amount in heart muscle, skeletal 
muscle, liver, brain and kidney whereas glutamic pyruvic 
transaminase (GPT) is a cystolic enzyme primarily present in the 
liver [20]. Upon damage to the tissues, an appreciable amount of 
these enzymes escapes into the blood stream, and this is brought out 
a sharp rise in the serum concentration of these enzymes [21]. The 
raised activity of these enzymes was reduced in the animals 
pretreated with indomethacin and the extracts. The results are 
shown in the fig. 1, 2. 
Unsaturated lipids are the normal constituents of the animal tissues, 
and they undergo oxidation to give rise to toxic peroxide ions (free 
radicals) [22]. Lipid peroxidation is known to occur in a variety of 
pathological conditions including rheumatoid arthritis, cancer and 
degenerative diseases associated with aging [23]. In inflammation, 
the major source of free radicals is the respiratory burst produced 
by the inflammatory cells such as macrophages, neutrophils, and 
eosinophils in response to particular stimuli. Also, the arachidonic 
cascade releases many free radicals in the process of prostaglandins 
biosynthesis [24]. Anti-inflammatory drugs are known to inhibit 
cellular oxidation [25]. Results demonstrate that the inflammation 
induced by carrageenan is accompanied by an increase in the in-
vitro output of lipid peroxides by the liver. Carrageenan may elicit a 
reaction in the paw which is transmitted to the liver which activates 
lysosomes as defense measure [25]. This activation causes an 
increase in the output of liver peroxides. Thus, lipid peroxide 
formation leads to rupture of the lysosomal membrane and allows 
the release of the contained hydrolytic enzyme [26]. Carrageenan 
injection to rat paw produced a significant increase in LPO level. 
However, both the doses of MHCL and AHCL significantly prevented 
carrageenan-induced increase in LPO level. Indomethacin 
administration also significantly decreased LPO level when 
compared to a control group that received carrageenan alone. The 
400 mg/kg and 200 mg/kg of MHCL were more effective in 
decreasing LPO level than 400 mg/kg and 200 mg/kg of AHCL (fig. 
3). Carrageenan treatment results in a significantly decrease in 
activity of SOD and GSH level. Which were increased by MHCL, AHCL 
and indomethacin (fig. 4 and 5). 
CONCLUSION 
Anti-inflammatory activity by carrageenan induces rat paw edema 
model was found in both the extracts i. e methanolic and aqueous 
extract of Hibiscus cannabinus. But the methanolic extract of Hibiscus 
cannabinus showed more significant anti-inflammatory activity. The 
study includes the investigation of the effects of MHCL and AHCL on 
some oxidative parameters such as LPO, SOD and GSH level during 
the acute phase of inflammation. Thus, a pharmacological basis has 
been achieved for the use of the plant against rheumatism and other 
related diseases.  
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